Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality

Figure 3. We obtained the risk trend ( ) and its 95% confidence band ( ) by using a quadratic-linear spline model. Circled
areas are proportional to inverse of study variance in the analysis. ADCS = Alzheimer's Disease Cooperative Study; AREDS =
Age-Related Eye Diseases Study; ATBC = Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group; CHAOS = Cambridge Heart
Antioxidant Study; DATATOP = Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism; GISSI-Prevenzione = Gruppo Italiano
per lo Studio della Sopravvivenza nell'Infarcto Miocardio Prevenzione; HOPE = Heart Outcomes Prevention Evaluation; MIN.VIT.AOX
= The Geriatrie/MINéraux, VITamines, et AntiOXydants Network; MRC/BHF HPS = Medical Research Council/British Heart Foundation
Heart Protection Study; PPP = Primary Prevention Project; PPS = Polyp Prevention Study; REACT = Roche European American Cataract
Trial; SPACE = Secondary Prevention with Antioxidants of Cardiovascular disease in Endstage renal disease; SU.VI.MAX = SUpplementation
en VItamines et Minéraux AntioXydants; VECAT = Vitamin E, Cataracts, and Age-Related Maculopathy; WAVE = Women's Angiographic
Vitamin and Estrogen.
Dose–response relationship between vitamin E supplementation and all-cause mortality in randomized, controlled trials.solid
curveshaded region
-
Published online before print
November 10, 2004,
Ann Intern Med
January 4, 2005
vol. 142
no. 1
37-46